این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Nanomedicine Journal، جلد ۱۲، شماره ۴، صفحات ۵۴۶-۵۹۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Antidiabetic nanotherapeutics of bioengineered silver and gold nanomaterials: a state‐of‐the‐art review
چکیده انگلیسی مقاله Diabetes is a global health challenge that significantly reduces quality of life and poses serious risks to human health. Despite advancements in medicine, current antidiabetic treatments often fail to effectively control the disease, particularly given the increasing prevalence of diabetes worldwide. This situation highlights the urgent need for innovative therapeutic approaches. Nanobiotechnology has emerged as a promising field for the eco-friendly production of nanosized metal-based particles with potential biomedical applications. Among these nanoparticles (NPs), biosynthesized colloidal silver and gold particles have attracted considerable interest due to their unique physicochemical properties and broad-spectrum biological activities. These nanostructures are created using biological resources such as plant extracts, algae, and microbes, resulting in particles with various sizes and shapes. Recent studies, including both in vitro and in vivo models, have explored the antidiabetic potential of these NPs. This review offers a comprehensive evaluation of the existing evidence, emphasizing their ability to inhibit key enzymes involved in diabetes (α-amylase and α-glucosidase) and to improve critical biomarkers in animal models. Notably, treatment with these NPs resulted in reductions in blood glucose and HbA1C levels, as well as increased insulin levels in diabetic animals. These findings indicate that bioengineered silver and gold nanomaterials can be considered innovative candidates for antidiabetic nanotherapeutics after future safety investigations.
کلیدواژه‌های انگلیسی مقاله Biosynthesis, Metal Nanoparticles, Silver nanoparticles, Gold Nanoparticles, Antidiabetic activity
نویسندگان مقاله | Hamed Barabadi
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran


| Hesam Noqani
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran


| Kamyar Jounaki
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


| Ayeh Sabbagh Kashani
Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.


| Fatemeh Ashouri
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


| Ebrahim Mostafavi
Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, United States. / Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States
نشانی اینترنتی https://nmj.mums.ac.ir/article_26433.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Review Paper
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات